From Stephen

Avg. Two Year Performance

(74%) Avg. Purchase Return
(32%) Compound
(6%) Avg. Sale Return
(3%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return11%16%35%(29%)(74%)
Purchase Success Rate2 of 22 of 21 of 20 of 20 of 2
Average Sale Return16%(2%)(143%)(48%)(6%)
Sale Success Rate1 of 10 of 10 of 10 of 10 of 1

Kiora Pharmaceuticals Inc

Drugs » Biotechnology

Executive Chairman, Director:

Holdings: 67.69K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--